Compared with those in the control group, both the adv and adv@Nap gel treatments significantly decreased intratumoral Ki67 expression but markedly increased caspase-3 levels, indicating that both therapies effectively inhibited tumor cell proliferation and promoted apoptosis (Figures S3A and S3B). This evidence concerns the gene CASP3 and neoplasm.